Bottom line
Is JGMCX a good fund? The bottom line
JGMCX is the Class C share class of Janus Henderson Triton Fund, a managed large blend mutual fund from Janus Henderson.
Its expense ratio is 1.76% — about $176 a year on every $10,000 invested, more expensive than 89% of large blend funds we track.
With $5.9 billion in net assets and 148 holdings, its largest position is Flex Ltd. (3.8%) and the top 10 make up 22.5% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.76%)
- 12b-1 marketing fee of 1% a year
Updated Nov 19, 2026
What JGMCX invests in
Janus Henderson Triton Fund seeks long-term growth of capital.
The Fund pursues its investment objective by investing at least 50% of its net assets in small- and medium-sized companies. The Fund may also invest in larger companies with strong growth potential. Small- and medium-sized companies are defined by portfolio management as those companies whose market capitalization falls within the 12-month capitalization range of the Russell 2500 tm Growth Index at the time of purchase. Market capitalization is a commonly used measure of the size and value of a company. The market capitalizations within the index will vary, but as of September 30, 2025, they ranged from approximately $4 million to $29.86 billion. The Fund may invest in shares of companies through initial public offerings and secondary offerings. Portfolio management applies a bottom-up approach in choosing investments. In other words, portfolio management looks at companies one at a…
From the fund's prospectus (filed Jan 28, 2026).
What JGMCX costs
On a $10,000 investment, JGMCX's 1.76% expense ratio costs about $176 a year. The prospectus estimates $1,955 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
JGMCX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Flex Ltd. | 3.75% |
| 2 | Teledyne Technologies, Inc. | 2.71% |
| 3 | Ligand Pharmaceuticals, Inc. | 2.63% |
| 4 | Glaukos Corp. | 2.49% |
| 5 | Aramark | 1.99% |
| 6 | Tower Semiconductor Ltd. | 1.93% |
| 7 | Sterling Infrastructure, Inc. | 1.80% |
| 8 | Revolution Medicines, Inc. | 1.78% |
| 9 | Lantheus Holdings, Inc. | 1.71% |
| 10 | Casey's General Stores, Inc. | 1.70% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 22.5% of the fund. See all top 25 holdings and asset mix →